COVID-19 infection thrombosis due to hemagluttination of antibodies and
COVID-19 antigens bound to erythrocytes
Abstract
A new pathogenic virus, COVID-19, appeared in 2019, in Wuhan, China,
typically causing fever, cough, diarrhea and fatigue and significant
mortality. COVID-19 has also shown about 80% genetic similarity to the
Severe Acute Respiratory Symptom (SARS) virus, which is already known to
be derived from a bat virus. Arterial thrombosis and venous thrombosis,
variously attributed to long term patient immobilizations, inflammation,
autoimmune reactions or endothelial cell damage to the blood vessels,
have also been reported for COVID-19 infections. However, there is
another explanation for thrombosis (blood clots) in many patients
infected with COVID-19.